Search - tctmd.com

Displaying 941 - 960 of 2141

Sort: Relevancy | Date

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

May 19, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

News Daily News

Melody Valve Yields Good Long-term Results, Especially With Pre-Stenting

Todd Neale

May 14, 2015

News Daily News

La Válvula Melody arroja Buenos Resultados a Largo Plazo Sobre Todo con la Pre-Implantación de un Stent

Todd Neale

May 14, 2015

News Daily News

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

May 14, 2015

News Daily News

Un Estudio Explora el Uso en el ‘Mundo Real’ de Prasugrel vs. Clopidogrel en el Manejo del SCA

May 12, 2015

News Daily News

Study Explores ‘Real-World’ Use of Prasugrel vs Clopidogrel in ACS

May 12, 2015

News Daily News

Orbital Atherectomy Continues to Show Efficacy, Cost Savings at 2 Years for Severe Calcifications

L.A. McKeown

May 11, 2015

News Daily News

La Aterectomía Orbital sigue siendo Eficaz y Rentable a los 2 Años en el Manejo de las Calcificaciones Severas

L.A. McKeown

May 11, 2015

News Daily News

Un Estudio de ‘Pacientes No Seleccionados’ Revela un Beneficio sobre la Supervivencia derivado de Revascularizaciones Completas en Pacientes Con y Sin Diabetes

Caitlin E. Cox

May 08, 2015

News Industry News

India Coronary Stent Market to be Tripled by 2021

May 05, 2015

News Industry News

Pre-Clinical Study Conducted at Mayo Clinic LOS ANGELES, NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company, today announced that results of an animal study of its Thin Film Nit

May 04, 2015

News Industry News

NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting

May 04, 2015

News Daily News

Unos Niveles Basales de Troponina I Más Altos se asocian a Placa Vulnerable en Pacientes sometidos a PCI

Caitlin E. Cox

May 01, 2015

News Daily News

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

April 29, 2015

News Daily News

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Yael L. Maxwell

April 29, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

April 29, 2015

News Daily News

El Tiempo Transcurrido entre PCI por Etapas y TAVR Influye Mínimamente en los Resultados a Corto Plazo

Yael L. Maxwell

April 29, 2015

Advertisement

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

Melody Valve Yields Good Long-term Results, Especially With Pre-Stenting

La Válvula Melody arroja Buenos Resultados a Largo Plazo Sobre Todo con la Pre-Implantación de un Stent

La Monoterapia con Aspirina Post-TAVR No es Menos Eficaz y es Posiblemente Más Segura que el Tratamiento Antiplaquetario Doble

Un Estudio Explora el Uso en el ‘Mundo Real’ de Prasugrel vs. Clopidogrel en el Manejo del SCA

Study Explores ‘Real-World’ Use of Prasugrel vs Clopidogrel in ACS

Orbital Atherectomy Continues to Show Efficacy, Cost Savings at 2 Years for Severe Calcifications

La Aterectomía Orbital sigue siendo Eficaz y Rentable a los 2 Años en el Manejo de las Calcificaciones Severas

Un Estudio de ‘Pacientes No Seleccionados’ Revela un Beneficio sobre la Supervivencia derivado de Revascularizaciones Completas en Pacientes Con y Sin Diabetes

India Coronary Stent Market to be Tripled by 2021

Pre-Clinical Study Conducted at Mayo Clinic LOS ANGELES, NeuroSigma®, Inc. (NeuroSigma), a California-based life sciences company, today announced that results of an animal study of its Thin Film Nit

NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting

Unos Niveles Basales de Troponina I Más Altos se asocian a Placa Vulnerable en Pacientes sometidos a PCI

Uso Viable de BRS en Lesiones Calcificadas Con Preparación Agresiva

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

El Tiempo Transcurrido entre PCI por Etapas y TAVR Influye Mínimamente en los Resultados a Corto Plazo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content